Prediction of the responsiveness to pharmacological chaperones: lysosomal human alpha-galactosidase, a case of study

BACKGROUND: The pharmacological chaperones therapy is a promising approach to cure genetic diseases. It relies on substrate competitors used at sub-inhibitory concentration which can be administered orally, reach difficult tissues and have low cost. Clinical trials are currently carried out for Fabr...

Descripción completa

Detalles Bibliográficos
Autores principales: Andreotti, Giuseppina, Guarracino, Mario R, Cammisa, Marco, Correra, Antonella, Cubellis, Maria Vittoria
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016270/
https://www.ncbi.nlm.nih.gov/pubmed/21138548
http://dx.doi.org/10.1186/1750-1172-5-36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016270/
https://www.ncbi.nlm.nih.gov/pubmed/21138548
http://dx.doi.org/10.1186/1750-1172-5-36

Ejemplares similares